FAT1 c.12929C>T ;(p.P4310L)

Variant ID: 4-187517765-G-A

NM_005245.3(FAT1):c.12929C>T;(p.P4310L)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


Predictive mutation signature of immunotherapy benefits in NSCLC based on machine learning algorithms.

Frontiers In Immunology
Liu, Zhichao Z; Lin, Guo G; Yan, Zeping Z; Li, Linduo L; Wu, Xingchen X; Shi, Jingrong J; He, Jianxing J; Zhao, Lei L; Liang, Hengrui H; Wang, Wei W
Publication Date: 2022

Variant appearance in text: FAT1: 12929C>T; P4310L
PubMed Link: 36238300
Variant Present in the following documents:
  • Table_1.xlsx, sheet 4
View BVdb publication page



EPHA5 mutation was associated with adverse outcome of atezolizumab treatment in late-stage non-small cell lung cancers.

Bmc Pulmonary Medicine
Li, Zhenxiang Z; Zhou, Qing Q; Wang, Qi Q; Wang, Haiyong H; Yue, Weiming W
Publication Date: 2022-09-19

Variant appearance in text: FAT1: 12929C>T; P4310L
PubMed Link: 36123678
Variant Present in the following documents:
  • 12890_2022_2161_MOESM2_ESM.xlsx, sheet 1
View BVdb publication page



Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation.

Nature Genetics
Morris, Luc G T LG; Kaufman, Andrew M AM; Gong, Yongxing Y; Ramaswami, Deepa D; Walsh, Logan A LA; Turcan, Şevin Ş; Eng, Stephanie S; Kannan, Kasthuri K; Zou, Yilong Y; Peng, Luke L; Banuchi, Victoria E VE; Paty, Phillip P; Zeng, Zhaoshi Z; Vakiani, Efsevia E; Solit, David D; Singh, Bhuvanesh B; Ganly, Ian I; Liau, Linda L; Cloughesy, Timothy C TC; Mischel, Paul S PS; Mellinghoff, Ingo K IK; Chan, Timothy A TA
Publication Date: 2013-03

Variant appearance in text: FAT1: Pro4310Leu
PubMed Link: 23354438
Variant Present in the following documents:
  • Main text
View BVdb publication page